tiprankstipranks
Trending News
More News >
Indaptus Therapeutics (INDP)
NASDAQ:INDP
US Market

Indaptus Therapeutics (INDP) Financial Statements

Compare
567 Followers

Indaptus Therapeutics Financial Overview

Indaptus Therapeutics's market cap is currently $7.43M. The company's EPS TTM is $-2.98; its P/E ratio is -0.11; Indaptus Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-4.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -15.37M$ -16.38M$ -14.91M$ -7.73M$ -3.60M
EBITDA$ -15.37M$ -16.38M$ -14.91M$ -7.73M$ -3.60M
Net Income$ -15.02M$ -15.42M$ -14.32M$ -7.71M$ -3.58M
Balance Sheet
Cash & Short-Term Investments$ 5.79M$ 13.36M$ 26.43M$ 39.13M$ 1.64M
Total Assets$ 7.34M$ 14.92M$ 28.06M$ 40.58M$ 1.78M
Total Debt$ 84.16K$ 175.05K$ 80.49K$ 169.33K$ 0.00
Net Debt$ -5.70M$ -13.19M$ -9.55M$ -38.96M$ -1.64M
Total Liabilities$ 3.39M$ 2.85M$ 3.43M$ 4.68M$ 2.02M
Stockholders' Equity$ 3.94M$ 12.08M$ 24.63M$ 35.90M$ -237.70K
Cash Flow
Free Cash Flow$ -12.32M$ -13.41M$ -13.25M$ -11.29M$ -3.32M
Operating Cash Flow$ -12.32M$ -13.41M$ -13.08M$ -11.29M$ -3.32M
Investing Cash Flow$ 0.00$ 17.14M$ -16.43M$ 447.75K$ 0.00
Financing Cash Flow$ 4.75M$ 0.00$ 0.00$ 48.34M$ 1.16M
Currency in USD

Indaptus Therapeutics Earnings and Revenue History

Indaptus Therapeutics Debt to Assets

Indaptus Therapeutics Cash Flow

Indaptus Therapeutics Forecast EPS vs Actual EPS